Nutraceutical composition and dosing regimen
AssigneeChronoSyn, LLC
InventorsMark Herbert Swanson, Paula A Witt-Enderby
Life of this patent
Estimating the term…
Abstract
The present invention is a nutraceutical formulation, intended for oral administration, comprising co-administered if not co-formulated melatonin together with at least one of strontium, Vitamin D, and Vitamin K or their analogues. The nutraceutical combination or formulation is designed to be taken by mouth within about two hours prior to bedtime, and in fact should not be taken at any other time. The combination therapy gives new and unexpectedly improved results compared to the administration of melatonin alone.
Claims19
A nutraceutical method of treating multiple indications relating to osteopenia and osteoporosis, comprising administering one time per day, within two hours of bedtime, at least one unit dose of melatonin combined with at least one dose of one of strontium, Vitamin D or Vitamin K or their analogues in an appropriate vehicle or dosage form for a human patient in whom such treatment is indicated.
A nutraceutical composition containing 0.1-20 mg melatonin, 0.1 mg to 3 g strontium (citrate), 0.1-10,000 IU vitamin D3 and 0.1-300 μg vitamin K2.
(canceled)
A nutraceutical composition containing 5 mg melatonin, 450 mg strontium (citrate), 2000 IU vitamin D3 and 60 μg vitamin K2.
Dependencies are inferred from the claim text.